help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on January 26, 2006, doi:10.1164/rccm.200507-1126OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200507-1126OCv1
173/10/1145    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kriegova, E.
Right arrow Articles by Petrek, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kriegova, E.
Right arrow Articles by Petrek, M.
American Journal of Respiratory and Critical Care Medicine Vol 173. pp. 1145-1154, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200507-1126OC


Original Article

Protein Profiles of Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis

Eva Kriegova*, Christian Melle*, Vitezslav Kolek, Beata Hutyrova, Frantisek Mrazek, Annett Bleul, Roland M. du Bois, Ferdinand von Eggeling and Martin Petrek

Faculty of Medicine, Palacky University, Olomouc, Czech Republic; Core Unit Chip Application, Institute of Human Genetics and Anthropology, Friedrich Schiller University, Jena, Germany; and Royal Brompton Hospital, London, United Kingdom

Correspondence and requests for reprints should be addressed to Martin Petrek, M.D., Palacky University, Medical Faculty, I.P. Pavlova Str. 6, CZ-775 20 Olomouc, Czech Republic. E-mail: petrekm{at}fnol.cz

Background: Pulmonary sarcoidosis is a multisystem granulomatous disease with various clinical phenotypes. So far, there has been little information on protein patterns (PPs) of bronchoalveolar lavage fluid (BALF) from patients with sarcoidosis and no data are available on PPs in clinical disease subtypes.

Objectives: To investigate the PP of BALF from patients with pulmonary sarcoidosis, to evaluate whether PPs reflect disease course as assessed by chest X-ray (CXR), and to compare PPs between patients with/without Löfgren's syndrome.

Methods: Surface-enhanced laser desorption/ionization–time-of-flight mass spectroscopy was applied to investigate PPs in unconcentrated BALF from 65 patients (CXR stage I, n = 32; CXR stage II, n = 22, CXR stage III, n = 11) and 23 healthy control subjects. The Mann-Whitney U test was used to detect differentially expressed protein peaks. After reversed-phase fractionation, peptide fingerprint mapping and immunodepletion were used to identify deregulated (up-regulated or down-regulated) proteins.

Results: Forty differentially expressed protein entities (2.75–185.62 kD) were detected in patients with pulmonary sarcoidosis versus control subjects (p < 0.05). Whereas 13 peaks (33%) were present across all CXR stages, 27 (67%) were specific for particular CXR stages. Comparison of PPs between CXR stage I patients with or without Löfgren's syndrome revealed 25 differentially expressed peaks. The total number of deregulated peaks and also of those associated with sarcoidosis as a whole were markedly lower in patients with Löfgren's syndrome in comparison with other sarcoid phenotypes. Human serum albumin, {alpha}1-antitrypsin, and protocadherin-2 precursor were identified from sarcoidosis-associated PP.

Conclusion: Surface-enhanced laser desorption/ionization–time-of-flight mass spectroscopy enables determination of protein patterns in sarcoid BALF and allows detection of protein patterns linked to a particular disease course.

Key Words: albumin • {alpha}1-antitrypsin • Löfgren's syndrome • protocadherin-2 • surface-enhanced laser desorption/ionization–time-of-flight mass spectroscopy




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
R. D. Gray, G. MacGregor, D. Noble, M. Imrie, M. Dewar, A. C. Boyd, J. A. Innes, D. J. Porteous, and A. P. Greening
Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases
Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 444 - 452.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. U. Wells and C. M. Hogaboam
Update in Diffuse Parenchymal Lung Disease 2006
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 655 - 660.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. S. Chen and D. R. Moller
Expression Profiling in Granulomatous Lung Disease
Proceedings of the ATS, January 1, 2007; 4(1): 101 - 107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Agostini and M. Facco
The promising future of proteomics in sarcoidosis.
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1053 - 1054.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society
  ATS Par News